Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 32

Trial Status

Completed1
Recruiting1
Terminated1
Other1

Role Distribution

Principal Investigator4
PI Rate100%

Activity Timeline

Clinical Trials (4)

NCT04371393Phase 3Terminated
MSCs in COVID-19 ARDS
Acute Respiratory Distress SyndromeCOVIDMesenchymal Stromal Cells+1 more
PrincipalinvestigatorStart date: 2020-04-30
NCT04045665Phase 3Recruiting
Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG
Atrial FibrillationBleedingStroke
PrincipalinvestigatorStart date: 2019-12-13
NCT03066050Active Not Recruiting
Long Term Follow Up for CTSN Mitral Valve Repair Studies
Coronary Artery DiseaseMitral Valve Insufficiency
PrincipalinvestigatorStart date: 2017-05-03
NCT02389894Not ApplicableCompleted
Neuroprotection in Patients Undergoing Aortic Valve Replacement
Aortic StenosisBrain InfarctionCerebrovascular Accident+1 more
Principalinvestigator

Research Network

Collaboration Network

8 collaborators·9 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Richard Weisel, MD

Toronto General Hospital

Similar
4 trials

Shared therapeutic areas:

Aortic Valve StenosisBrain InfarctionStroke+2 more

Worked with same sponsors:

Canadian Institutes of Health Research (CIHR)Icahn School of Medicine at Mount Sinai+1 more
Collaborated on 2 trials
Similarity Score58%

Peter Smith, MD

Duke University

Moderately Similar
1 trials

Shared therapeutic areas:

Respiratory Distress Syndrome, AcuteCOVIDMesenchymal Stromal Cells+1 more

Worked with same sponsors:

Icahn School of Medicine at Mount SinaiMesoblast, Inc.+1 more
Collaborated on 1 trial
Similarity Score44%

Michael Mack, MD

Baylor Research Institute

Moderately Similar
1 trials

Shared therapeutic areas:

Respiratory Distress Syndrome, AcuteCOVIDMesenchymal Stromal Cells+1 more

Worked with same sponsors:

Icahn School of Medicine at Mount SinaiMesoblast, Inc.+1 more
Collaborated on 1 trial
Similarity Score44%

John Alexander, MD

Duke University

Moderately Similar
1 trials

Shared therapeutic areas:

Atrial FibrillationHemorrhageStroke

Worked with same sponsors:

Icahn School of Medicine at Mount SinaiNational Heart, Lung, and Blood Institute (NHLBI)+1 more
Collaborated on 1 trial
Similarity Score34%

Marc Gillinov, MD

The Cleveland Clinic

Moderately Similar
6 trials

Shared therapeutic areas:

Atrial FibrillationHemorrhageStroke

Worked with same sponsors:

Icahn School of Medicine at Mount SinaiNational Heart, Lung, and Blood Institute (NHLBI)+1 more
Collaborated on 1 trial
Similarity Score34%

Vivek Reddy, MD

Icahn School of Medicine at Mount Sinai

Related
28 trials

Shared therapeutic areas:

Atrial FibrillationStrokeHemorrhage

Worked with same sponsors:

Icahn School of Medicine at Mount Sinai
Similarity Score8%

Anissa MEGZARI

Centre Hospitalier Universitaire de Nīmes

Related
29 trials

Shared therapeutic areas:

StrokeHemorrhage
Similarity Score5%

Paolo Bonato, PhD

Spaulding Rehabilitation Hospital

Related
19 trials

Shared therapeutic areas:

Stroke
Similarity Score3%

loic MONDOLONI

Assistance Publique Hopitaux De Marseille

Related
28 trials

Shared therapeutic areas:

Atrial Fibrillation
Similarity Score3%

emilie garrido pradalie

APHM

Related
35 trials

Shared therapeutic areas:

Stroke
Similarity Score3%

Publications (0)

No publications found for this investigator.

Clinical Trials (4)

Showing 4 of 4 trials

NCT04371393Phase 3PrincipalInvestigator

MSCs in COVID-19 ARDS

Acute Respiratory Distress SyndromeCOVIDMesenchymal Stromal Cells+1 more
Terminated
NCT04045665Phase 3PrincipalInvestigator

Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG

Atrial FibrillationBleedingStroke
Recruiting
NCT03066050PrincipalInvestigator

Long Term Follow Up for CTSN Mitral Valve Repair Studies

Coronary Artery DiseaseMitral Valve Insufficiency
Active Not Recruiting
NCT02389894Not ApplicablePrincipalInvestigator

Neuroprotection in Patients Undergoing Aortic Valve Replacement

Aortic StenosisBrain InfarctionCerebrovascular Accident+1 more
Completed

All 4 trials loaded